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XRCC1 Stimulates Human Polynucleotide Kinase
Activity at Damaged DNA Termini
and Accelerates DNA Single-Strand Break Repair
damage during DNA base excision repair. In contrast,
SSBs resulting from DNA sugar damage arise directly,
from attack by endogenous reactive oxygen species
(ROS) or those generated by hydrogen peroxide or ioniz-
ing radiation (Ward, 1998). The termini of SSBs are fre-
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tional end groups that must be processed to restoreUniversity of Manchester
Oxford Road M13 9PT 39-hydroxyl and 59-phosphate moieties before single-
strand break repair (SSBR) can be completed by gapUnited Kingdom
†Experimental Oncology filling and DNA ligation.
One polypeptide implicated in the repair of a broadCross Cancer Institute
Department of Oncology range of SSBs is XRCC1. XRCC1 was the first human
gene involved in SSBR to be cloned and cells lackingUniversity of Alberta
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Thompson and West, 2000). The importance of XRCC1Lady Davis Institute for Medical Research
Sir Mortimer B. Davis Jewish General Hospital to genetic stability is indicated by an elevated frequency
of spontaneous chromosome aberrations and deletionsMontreal, Quebec H3T 1E2
Canada in XRCC1 mutant cells and by embryonic lethality in
XRCC12/2 mice (Tebbs et al., 1999; Thompson and
West, 2000). In addition, a genetic polymorphism has
been identified in human XRCC1 that is correlated with
elevated somatic mutation and cancer risk (Shen et al.,Summary
1998; Lunn et al., 1999; Sturgis et al., 1999; Divine et al.,
2001). At the molecular level, XRCC1 interacts with polyXRCC1 protein is required for DNA single-strand break
(ADP-ribose) polymerase (Caldecott et al., 1996; Massonrepair and genetic stability but its biochemical role is
et al., 1998), DNA polymerase-b (Caldecott et al., 1996;unknown. Here, we report that XRCC1 interacts with
Kubota et al., 1996), and DNA ligase IIIa (Caldecott ethuman polynucleotide kinase in addition to its estab-
al., 1994, 1995). Despite these observations, however,lished interactions with DNA polymerase-b and DNA
the biochemical role of XRCC1 remains unclear. Here,ligase III. Moreover, these four proteins are coassoci-
we have employed human XRCC1 as bait in a yeastated in multiprotein complexes in human cell extract
2-hybrid screen in an attempt to identify additional pro-and together they repair single-strand breaks typical
teins with which XRCC1 interacts and to determine theof those induced by reactive oxygen species and ioniz-
role of this protein in SSBR.ing radiation. Strikingly, XRCC1 stimulates the DNA
kinase and DNA phosphatase activities of polynucleo-
tide kinase at damaged DNA termini and thereby ac- Results
celerates the overall repair reaction. These data iden-
tify a novel pathway for mammalian single-strand XRCC1 Protein Interacts with Human
break repair and demonstrate a concerted role for Polynucleotide Kinase
XRCC1 and PNK in the initial step of processing dam- Yeast Y190 cells harboring the 2-hybrid construct pAS-
aged DNA ends. XRCC1 were employed to screen a human cDNA library
for genes that encode XRCC1-interacting proteins. From
1.5 3 106 transformants, 186 clones were obtained thatIntroduction
displayed histidine prototrophy and b-galactosidase
activity. Of thirty-nine clones so far examined, twoDNA damage is a major threat to genetic stability as
indicated by the cancer-prone phenotype of human dis- encoded unknown proteins, thirty-one encoded DNA
polymerase-b (Polb), and four encoded DNA ligase IIIaeases in which DNA repair is defective. Contributors to
this threat are the thousands of cellular DNA single- (Lig3). Intriguingly, the remaining two clones encoded
human polynucleotide kinase (PNK), a protein pos-strand breaks (SSBs) that arise each day from DNA base
damage or DNA sugar damage. If not repaired, such sessing 39-DNA phosphatase and 59-DNA kinase activity
and which can thus restore normal termini to DNA strandbreaks can be converted into double-strand breaks dur-
ing DNA replication and can result in chromosome insta- breaks possessing 39-phosphate and 59-hydroxyl end
groups (Jilani et al., 1999; Karimi-Busheri et al., 1999).bility and cell death. SSBs can arise from DNA base
damage indirectly, via the enzymatic excision of base 39-phosphate termini are present at 70% of direct SSBs
induced by endogenous ROS or ionizing radiation, and
also at any SSBs arising at abasic sites via enzymatic§ To whom correspondence should be addressed (e-mail: keith.
or thermal b,d elimination (Bailly et al., 1989; Sugiyamacaldecott@man.ac.uk).
k These authors contributed equally to this work. et al., 1994; Ward, 1998). 59-hydroxyl termini have been
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Figure 1. Human XRCC1 and PNK Physically
Interact
(A) Pair-wise yeast 2-hybrid analysis was con-
ducted on yeast Y190 cells harboring the con-
structs indicated in the key. Cells were plated
on complete medium (“YPD”), minimal me-
dium lacking leucine and tryptophan to select
for both pAS and pACT constructs (“-leu, -trp”),
and minimal medium additionally lacking histi-
dine and containing 50 mM 3-aminotriazole (3-
AT) to select for 2-hybrid protein–protein inter-
actions (“-leu, -trp, -his”). Colonies from YPD
plates were examined for b-galactosidase
activity by a colony filter assay (“b-gal”).
Strains exhibiting both histidine-prototrophy
and b-gal activity are circled in the key.
“Cured 26” refers to a derivative of clone 26
generated by selecting for loss of pAS-X plas-
mid by growth on media containing cyclohex-
amide.
(B) Cell extract from yeast Y190 cells harbor-
ing the indicated 2-hybrid constructs was
fractionated by SDS-PAGE and immunoblot-
ted with anti-XRCC1 33-2-5 mAb or anti-PNK
or anti-Lig3 TL25 polyclonal antisera. Itali-
cized numbers refer to the Y190 strains in the
key in (A).
(C) Cell extract from Y190 cells harboring
pAS-X and pACT-PNK (library clone 26) was
immunoprecipitated with anti-PNK antisera
(top panels), preimmune sera (middle panels),
or anti-XRCC1 mAb (bottom panels). Aliquots
of the crude extract (“extract”) and immuno-
precipitates (“IP”) were fractionated by SDS-
PAGE and immunoblotted with anti-PNK antisera (left panels) or anti-XRCC1 mAb (right panels).
(D) Cell extract (30 mg total protein) from E. coli cells lacking human PNK (“2”) or weakly expressing this protein (“1”) were fractionated by
SDS-PAGE and transferred to nitrocellulose. Nitrocellulose strips were either stained for total protein with amido black (left two lanes),
immunoblotted with anti-PNK polyclonal antisera (middle two lanes), or incubated with 32P-labeled XRCC1 by far-Western analysis (right two
lanes) as previously described (Wei et al., 1995).
detected in DNA recovered from irradiated thymocytes amido black (Figure 1D, left panel) or electroblotted to
nitrocellulose. The nitrocellulose filters were subse-(Coquerelle et al., 1973; Lennartz et al., 1975; Ward,
1998), and both 59-hydroxyl and 39-phosphate termini quently either immunoblotted with anti-PNK antibodies
(Figure 1D, middle panel) or incubated with a [32P]-are present at SSBs created by abortive topoisomerase
I activity (Nitiss, 1998). Despite its potential utility at XRCC1 probe (Figure 1D, right panel). Although PNK
was expressed at levels too low to be detected withSSBs, however, direct evidence for a role for PNK in
mammalian DNA repair has been lacking. amido black, both anti-PNK antibodies and [32P]-XRCC1
detected the recombinant polypeptide. Taken together,The His1/b-gal1 phenotype of a Y190: pAS-XRCC1
library clone harboring pACT-PNK (Clone “26”) is pre- these data demonstrate that PNK protein interacts with
XRCC1, providing the first direct evidence for a DNAsented (Figure 1A, “1”), along with a number of positive
and negative controls. Loss of pAS-XRCC1 from Clone kinase/DNA phosphatase activity in mammalian SSBR.
26, achieved by selecting for growth in the presence of
cycloheximide, resulted in a corresponding loss of the The Coassociation of XRCC1, PNK, Polb,
and Lig3 in Multiprotein ComplexesHis1/b-gal1 phenotype (Figure 1A, “4”), and reintroduc-
tion of pAS-XRCC1 by transformation restored this phe- To determine whether XRCC1 and PNK are associated
in mammalian cells, we examined whether they could benotype (Figure 1A, “3”). Cotransformation of empty Y190
cells with purified pAS-XRCC1 and pACT-PNK plasmids coimmunoprecipitated from human cell extract. Indeed,
both XRCC1 and PNK were coprecipitated from A549similarly conferred a His1/b-gal1 phenotype (Figure 1A,
“2”). Immunoblotting confirmed that the strains em- cell extract by either anti-XRCC1 or anti-PNK antibodies
(Figure 2A, top panel). XRCC1 also interacts and is asso-ployed expressed the expected proteins (Figure 1B). Bio-
chemical evidence for an interaction between XRCC1 and ciated in cells with Lig3 and Polb (Caldecott et al., 1994,
1995, 1996; Kubota et al., 1996). In fact, almost all cellularPNK emerged from the observed coimmunoprecipitation
of these proteins from Y190:pAS-XRCC1/pACT-PNK ex- XRCC1 and Lig3 are tightly bound together, and the
intracellular stability of Lig3 is dependent on this interac-tract by either anti-XRCC1 or anti-PNK antibodies (Figure
1C), and from Far-western analysis (Figure 1D). For the tion (Caldecott et al., 1995; Taylor et al., 1998, 2000a). We
therefore determined whether PNK also coprecipitateslatter approach, extracts from E. coli lacking human PNK
or expressing low levels of this protein were fractionated with Polb and Lig3, to examine whether all four proteins
might be coassociated in a multiprotein complex. In-by SDS-PAGE and either stained for total protein with
A Pathway for Mammalian Single-Strand Break Repair
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Figure 2. PNK Interacts and Coassociates with XRCC1, Polb, and Lig3
(A) Cell extract from human A549 cells was subjected to immunoprecipitation with anti-XRCC1 polyclonal antisera (GeneTex inc. San Antonio)
(lane 1, top panel), anti-Polb polyclonal antisera (lane 1, middle panel), anti-Lig3 polyclonal antisera (lane 1, bottom panel), preimmune rabbit
serum (lane 2, all panels), or anti-PNK polyclonal antisera (lane 3, all panels). Aliquots of the immunoprecipitates (lanes 1–3, all panels) and
A549 total cell extract (lanes 4, top and middle panels) were fractionated by SDS-PAGE and immunoblotted for XRCC1 and PNK (top panel),
Polb and PNK (middle panel), or Lig3 and PNK (bottom panel).
(B) HeLa cell extract was subjected to immunoprecipitation with murine IgG (lane 1), anti-XRCC1 mAb (lane 2), anti-PNK antiserum (ACIV,
lane 3), rabbit preimmune serum (lane 4), or rabbit 1186 anti-Lig-1 antiserum (lane 5). The immunoprecipitates were incubated with [a-32P]ATP
to adenylate DNA ligase polypeptides prior to their fractionation by SDS-PAGE. Labeled proteins were detected by autoradiography. “L1”
and “L3” denote Lig-1 and Lig-3.
(C) XRCC1, PNK, Polb, and Lig3 were examined for interaction with each other by 2-hybrid analysis. Yeast Y190 cells harboring the 2-hybrid
constructs indicated at the bottom (“1–5”) were plated onto minimal medium lacking leucine and tryptophan to select for pAS and pACT
constructs (“-leu, -trp”), or minimal medium additionally lacking histidine and containing 50 mM 3-AT to select for 2-hybrid protein–protein
interaction (“-leu, -trp, -his”). Colonies from complete media were examined for b-gal activity (“b-gal”) by a colony filter assay.
(D) Left, summary of immunoprecipitation and yeast 2-hybrid experiments. 1(Caldecott et al., 1994); 2(Caldecott et al., 1995); 3(Caldecott et al.,
1996); 4(Kubota et al., 1996). Right, alternative models to explain the summarized data, depicting the association of XRCC1, PNK, Polb, and
Lig3 in a single protein complex or multiple independent complexes. The two possibilities are not mutually exclusive. Note that XRCC1 and
Lig3 are always bound together.
deed, both anti-Polb and anti-Lig3 antibodies immuno- We next conducted further 2-hybrid experiments to
determine whether additional interactions occur be-precipitated PNK, and anti-PNK antibodies immunopre-
cipitated both Polb and Lig3 (Figure 2A, middle and tween these four proteins, other than those identified
for XRCC1, as might be expected if they comprise onebottom panels). The coimmunoprecipitation of Lig3 with
PNK was also evident if anti-PNK immunoprecipitates or more multiprotein complexes. Indeed, in addition to
interacting with XRCC1 (Figure 2C, lanes 1 and 3), Polbwere incubated with [a-32P]ATP to detect DNA ligases
via their ability to form a covalent complex with AMP and Lig3 proteins both interacted with PNK (Figure 2C,
lanes 4 and 5). In contrast, Polb and Lig3 did not appear(Figure 2B). A comparison of the ratio of signal intensities
in the immunoprecipitated material and total cell extract, to interact with each other (Figure 2C, lane 2). A summary
of these and previously published data, and a schematicin conjunction with gel filtration and immunofluores-
cence experiments, suggest that the association of PNK of the possible multiprotein complexes minimally re-
quired to explain these data, is presented (Figure 2D).and Polb with XRCC1-Lig3 complex is normally limited
to approximately 5%–15% of the total cellular comple-
ment of each protein (data not shown). Nevertheless, XRCC1 Accelerates SSBR Reconstituted
with Recombinant Human Proteinsthese data indicate that a proportion of these four pro-
teins interact with each other and are coassociated in The observation that XRCC1 binds a DNA kinase/phos-
phatase (PNK), a DNA polymerase (Polb), and a DNAhuman cell extract at any one time, either as a single
multiprotein complex or as multiple smaller complexes. ligase (Lig3) is intriguing, since the latter three proteins
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SSB (lane 4). Omission of Polb or Lig3 from the reaction
also prevented repair, resulting in accumulation of the
expected 20-mer or 21-mer intermediates, respectively
(lanes 5 and 6). Because the radiolabel in the above
experiments was present on the 20pmer, only the phos-
phatase activity of PNK could be directly measured.
However, the observed ability of Lig3 to complete repair
confirmed that DNA kinase activity did occur during the
SSBR reaction because the presence of a 59-terminal
phosphate is a prerequisite for DNA ligation.
If PNK, Polb, and Lig3 comprise the core enzymatic
activities sufficient for SSBR, what role does XRCC1
play in this process? Although XRCC1 was dispensable
in the reactions described above, which contained each
recombinant protein at 25 nM, it was considered possi-
ble that XRCC1 may serve to stimulate SSBR if one or
more of the core enzymatic activities are limiting. In-
deed, a requirement for XRCC1 for SSBR was observed
if the concentration of each protein was reduced to 4
nM (Figure 4A, lanes 7 and 8). Additional protein titration
experiments confirmed that XRCC1 stimulated SSBR
over a range of concentrations of PNK, Polb, and Lig3
(Figure 4B, lanes 1–9). Moreover, although XRCC1 was
unable to stimulate SSBR at the lowest concentration
of proteins employed (each protein at 1.6 nM), it did so
if the amount of XRCC1 in this reaction was increased
5-fold (Figure 4B, lanes 5, 9, and 10). These data demon-
strate that XRCC1 accelerates SSBR in vitro.
XRCC1 Stimulates the DNA Phosphatase
and DNA Kinase Activities of PNK
In contrast to substrate-1, the repair of a derivative of thisFigure 3. In Vitro SSBR Reactions
substrate that lacks damaged termini (substrate-2) did not(A) Recombinant human proteins. 1 mg of each of the indicated
require PNK (Figure 4C, lane 4). This confirms that PNKproteins purified from E. coli were fractionated by SDS-PAGE and
was required during the repair of substrate-1 for pro-stained with Coomassie blue. The position of molecular weight
markers (Biorad) is indicated. cessing damaged termini. More interestingly, XRCC1 was
(B) Structure of the oligonucleotide duplex substrate-1 and the pre- similarly dispensable for repair of substrate-2, indicating
dicted intermediates of its repair. The initial duplex substrate (top) that the requirement for this protein during the repair of
harbors a 1 bp gap with 59-hydroxyl and 39-phosphate termini. The
substrate-1 was also for processing damaged DNA endsasterisk denotes the position of a 32P label. [1] The phosphatase
(Figure 4C, lanes 7 and 8). What role might XRCC1 playactivity of PNK restores a conventional 39-hydroxyl terminus to the
in this process? The simplest explanation for these re-32P-labeled 20-pmer creating a 32P-labeled 20-mer. The kinase activ-
ity of PNK also restores a conventional 59-phosphate terminus but sults is that XRCC1 stimulates the activity of PNK if the
this event is not detected unless [g-32P]ATP is present. [2] Polb fills concentration of the latter is limiting during SSBR. To
the 1 bp gap (dotted line), creating a 32P-labeled 21-mer. [3] Lig3 test this notion, we allowed the products of DNA kinase
ligates the single-strand nick, creating a 32P-labeled 45-mer. and DNA phosphatase activity to accumulate during the
SSBR reaction by omitting dNTPs and thereby pre-
venting subsequent gap filling and DNA ligation. DNA
together possess the core enzymatic activities theoreti- phosphatase activity was greater than 8-fold more effi-
cally sufficient for the repair of cellular SSBs possessing cient in reactions containing PNK, XRCC1, Polb, and
39-phosphate and/or 59-hydroxyl termini. To examine this Lig3 than in reactions containing PNK alone (Figure 5A,
possibility, we attempted to reconstitute SSBR using compare panels 1 and 2). Omission of PNK from the reac-
recombinant human proteins and a defined oligonucleo- tion abolished phosphatase activity, confirming that the
tide duplex substrate. The recombinant proteins and extra activity conferred by one or more of XRCC1, Polb,
oligonucleotide duplex employed for these experiments, and Lig3 reflected stimulation of PNK rather than another
along with the expected DNA intermediates of SSBR, are source of phosphatase (Figure 5A, panel 4). Although the
presented (Figures 3A and 3B). The repair of substrate 1 39-phosphatase activity of PNK was greatest in the pres-
was completed within 1 hr when incubated with a mix- ence of all three proteins (Figure 5A, panel 2), XRCC1
ture of the four proteins, as indicated by the complete was both required (Figure 5A, panel 3) and sufficient
conversion of labeled 20pmer to 45-mer (Figure 4A, (Figure 5A, panel 5) for most of this stimulation. In con-
compare lanes 1 and 2). Whereas omission of XRCC1 trast, Polb, Lig3, and BSA were unable to stimulate PNK
did not appear to influence the repair reaction under the phosphatase activity by themselves (Figure 5A, com-
conditions employed (Figure 4A, lane 3), omission of pare panels 1 and 6–8). These experiments demonstrate
PNK prevented removal of the 39-phosphate from the that XRCC1 stimulates the 39-phosphatase activity of
PNK.20pmer and consequently any further processing of the
A Pathway for Mammalian Single-Strand Break Repair
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To examine whether XRCC1 also stimulates the
59-kinase activity of PNK, a derivative of substrate-1
was employed that was unlabeled and in which the only
damaged terminus was a 59-hydroxyl (Figure 5B, top
right). In addition, the DNA kinase reactions were con-
ducted in the presence of [g-32P]ATP. The 59-kinase ac-
tivity of PNK was more than 6-fold greater in the pres-
ence of XRCC1, Polb, and Lig3 than when present alone
(Figure 5B, compare panels 1 and 2). Once again, XRCC1
was required and sufficient for much of this stimulation
(Figure 5B, compare panel 1 with 2, 3, and 5), though it
was noted that Lig3 also stimulated PNK to some extent
(Figure 5B, compare panels 1 and 7). Taken together,
these data demonstrate that XRCC1 stimulates both the
39-DNA phosphatase and 59-DNA kinase activities of
PNK and thereby accelerates SSBR, in vitro.
XRCC1 Is Required for End Processing and SSBR
Conducted by Whole-Cell Extract
We wished to examine whether XRCC1 is required to
stimulate PNK activity in cells. We therefore compared
whole-cell extract prepared from XRCC1 mutant EM9
cells lacking XRCC1 with that from EM9 cells corrected
with human XRCC1 cDNA for their ability to support
SSBR in vitro. We have demonstrated previously that
SSBR proficiency and cellular resistance to DNA dam-
age is restored in EM9 cells that express human XRCC1
(denoted EM9-X cells) (Caldecott et al., 1992; Taylor et
al., 2000a). Strikingly, EM9 cell extracts were less able
to conduct repair of substrate-1 than were extracts from
EM9-X (Figure 6A, top panel, compare lanes 2–4 and
8–10). Furthermore, the addition of recombinant human
XRCC1 to EM9 cell extract stimulated SSBR to a level
similar or greater than that observed with EM9-X cell
extract (Figure 6A, lanes 11–13). Recombinant XRCC1
stimulated SSBR supported by EM9-X cell extract to a
much lesser extent, suggesting that its ability to stimu-
late EM9 cell extract reflected true complementation
of the XRCC1 defect (Figure 6A, lanes 5–7). Strikingly,
Figure 4. XRCC1 Accelerates SSBR
(A) 45-mer duplex substrate-1 (80 nM) harboring a 1 bp gap with
39-phosphate and 59-hydroxyl termini was incubated in the absence
of protein (lane-1) or in the presence of 25 nM (lanes 2–6) or 4 nM
(lanes 7and 8) of each of the indicated recombinant human proteins
for 1 hr at 378C. Reaction products were separated by denaturing
PAGE (15% gels) and visualized by phosphorimager.
(B) 45-mer duplex substrate-1 (80 nM) was incubated in the absence
of recombinant proteins (lane 1) or in the presence of 1.6–8.0 nM
each of human PNK, Polb, and Lig3 (lanes 2–9), with (lanes 2–5)
or without (lanes 6–9) the same amount of XRCC1. One reaction
contained 1.6 nM each of PNK, Polb, and Lig3 and 8 nM XRCC1
(lane 10). Reaction products were analyzed as above.
(C) 45-mer duplex substrate-2 (80 nM), which differs from substrate-1
by the absence of damaged termini, was incubated in the absence
of protein (lane 1) or in the presence of 25 nM (lanes 2–6) or 4 nM
(lanes 7and 8) of each of the indicated recombinant human proteins
for 1 hr at 378C. Reaction products were analyzed as above.
The structure of the substrates employed in these experiments is
shown at the top of each panel, with the position of the 32P-labeled
phosphate indicated by an asterisk. The position migrated by the
20-pmer, 20-mer, 21-mer, and the 45-mer are also indicated. The
slight smearing of 20-mer, 20-pmer, and 21-mer in some lanes (e.g.,
[A], lane 1) is an artifact of the electrophoresis conditions employed.
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Figure 5. XRCC1 Stimulates the DNA Kinase and DNA Phosphatase Activities of PNK
(A) 39-phosphatase assay: substrate-1 (80 nM) was incubated in the presence or absence, as indicated on the far right, of 0–25 nM of each
of PNK (“P”), XRCC1 (“X”), Polb (“B”), and Lig3 (“L3”), for 1 hr at 378C. One set of reactions (panel 8) included 0–25 nM PNK and twice this
amount of BSA (0–50 nM, respectively). dNTPs were omitted from the reactions to allow the products of end processing to accumulate. Dotted
lines denote the positions of 20-pmer substrate and the 20-mer product of 39-phosphatase activity.
(B) 59-kinase assay: A modified version of substrate-1 (80 nM) was incubated as described above but included the additional presence of
[g-32P]ATP. Reaction products were resolved by denaturing PAGE. The position of the 24-mer product of 59-kinase activity is indicated.
however, XRCC1 was largely redundant in SSBR reac- human XRCC1 did not stimulate the reaction further
(Figure 6B, lanes 14–17).tions in which end processing was not required since
little difference was observed between the ability of EM9 To examine whether recombinant PNK might also be
able to circumvent the requirement for XRCC1 in vivo,and EM9-X extracts to conduct SSBR of substrate-2,
and recombinant human XRCC1 did not stimulate this we attempted to introduce this protein into XRCC1 mu-
tant EM9 cells by electroporation. We have shown pre-reaction (Figure 6A, lower panel). These data demon-
strate that XRCC1 stimulates the repair of SSBs with viously that recombinant human XRCC1 restores EMS
resistance in electroporated EM9 cells, whereas unre-damaged termini in reactions reconstituted with whole
cell extract. To examine whether this requirement for lated proteins such as BSA or maltose binding protein
do not (Caldecott et al., 1995). Intriguingly, PNK didXRCC1 for end processing reflects the ability of this
protein to stimulate PNK activity, we examined whether increase EMS resistance in electroporated EM9 cells,
though to a lesser extent than did XRCC1 (Figure 7A,addition of recombinant human PNK to EM9 cell extract
would circumvent the need for XRCC1. Indeed, the addi- left panel). The partial nature of this correction is not
surprising, since it is likely that other XRCC1 functionstion of PNK to EM9 extract stimulated SSBR to a level
comparable to that stimulated by recombinant XRCC1 are also important for SSBR in vivo (e.g., the interactions
with Lig3, Polb, and PARP). Further support for a role(Figure 6B, lanes 6–13) and the additional presence of
A Pathway for Mammalian Single-Strand Break Repair
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Figure 6. XRCC1 Stimulates SSBR Mediated
by Whole-Cell Extract
(A) 80 nM substrate-1 (top panel) or sub-
strate-2 (bottom panel) was incubated in the
absence of protein (lane 1) or with 2.5–10 mg
of EM9-X (lanes 2–7) or EM9 (lanes 8–13) cell
extract protein at 378C for 1 hr (10 ml reaction
volume). Where indicated, cell extracts were
supplemented with 0.5 mg recombinant hu-
man XRCC1 (“1X”) per 20 mg total protein.
(B) Substrate-1 (80 nM) was incubated in the
absence of protein (lane-1) or with 1.25–10
mg EM9 cell extract protein at 378C for 1 hr
(10 ml reaction volume). Where indicated, ex-
tracts were supplemented with 0.5 mg re-
combinant human XRCC1 (“1X”) or PNK
(“1PNK”), or both, per 20 mg total protein.
Reaction products were separated by dena-
turing PAGE and visualized by phos-
phorimager.
for PNK in DNA repair in vivo emerged from the observa- strated by the observation that pre-blocking the anti-
Polb antibody with purified recombinant human Polbtion that HeLa cells transfected with human PNK cDNA
exhibited elevated resistance to EMS, compared to ablated its ability to inhibit the reaction (Figure 7B, top
panel, lanes 10–13). This pre-blocking step had muchHeLa cells transfected with empty vector or with PNK
cDNA cloned in anti-sense orientation (Figure 7A, right less effect on the SSBR reaction in the absence of anti-
Polb antibodies (Figure 7B, top panel, lanes 14–17). Thepanel). The expression of human PNK in E. coli has
similarly been observed to increase cellular resistance anti-Polb antibodies also inhibited SSBR if simply added
to the reaction, consistent with their ability (Singhal etto alkylating agents (Jilani et al., 1999). The most likely
role for PNK following EMS is at SSBs arising from aba- al., 1995) to neutralize Polb activity (Figure 7B, bottom
panel, compare lanes 2–5 with 6–9). Addition of anti-sic sites via enzymatic or thermal b,d-elimination, since
such breaks possess 39-phosphate damaged termini Lig3 polyclonal antibodies to the reaction also inhibited
SSBR (Figure 7B, bottom panel lanes 10–13), whereas(Bailly et al., 1989; Wilson, et al., 1998).
Taken together, these data describe a concerted role anti-Lig1 monoclonal antibodies did not (Figure 7B, bot-
tom panel lanes 14–17). These data suggest that bothfor XRCC1 and PNK in processing damaged DNA termini
during mammalian SSBR. Polb and Lig3 were required for SSBR conducted by
whole-cell extract, under the conditions employed.
DNA Polymerase-b and DNA Ligase III Are Required
for SSBR Conducted by Whole-Cell Extract Discussion
Following end processing by XRCC1 and PNK, SSBR
can be completed by gap filling and DNA ligation. Processing Ends to Begin Repair
The single-strand break repair protein XRCC1 is re-XRCC1 and PNK interact with Lig3 and Polb in cells,
and the latter two proteins were able to conduct these quired for genetic stability and for embryonic viability
in mice. However, the biochemical role of this polypep-roles during the repair of direct SSBs by recombinant
human proteins (see Figure 4). To examine whether Polb tide has remained elusive. Here, we demonstrate that
XRCC1 interacts with human polynucleotide kinaseand/or Lig3 might mediate these roles in cells, we exam-
ined the effect of anti-Lig3 and neutralizing anti-Polb (PNK), providing the first direct evidence for the activity
of this dual DNA kinase/DNA phosphatase during mam-polyclonal antibodies on SSBR conducted by whole-
cell extract. Strikingly, the immunodepletion of Polb malian SSBR (Jilani et al., 1999). Moreover, we have
reconstituted SSBR reactions using recombinant humanfrom wild-type EM9-X extract strongly inhibited the
SSBR reaction (Figure 7B, top panel, compare lanes 2–5 proteins and show that XRCC1 stimulates both the DNA
kinase and DNA phosphatase activities of PNK at dam-with 6–9). The specificity of this inhibition was demon-
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mini can be replaced by increasing the concentration
of PNK, suggesting that this role is to stimulate PNK.
Second, XRCC1 mutant cells are hypersensitive to agents
that can induce SSBs possessing 59-hydroxyl or 39-phos-
phate damaged termini, such as ionizing radiation, hy-
drogen peroxide, and camptothecin (Thompson and
West, 2000).
Completing Repair after Processing Ends
Once XRCC1 and PNK have restored the termini of direct
SSBs to their conventional chemistry, SSBR can be
completed by gap filling and DNA ligation. The observa-
tion that XRCC1 and PNK both interact and coassociate
with Polb and Lig3 strongly implicates the latter two
polypeptides in these processes. Consistent with this
notion, both anti-Lig3 and neutralizing anti-Polb anti-
bodies inhibited SSBR mediated by wild-type extract,
indicating that these polypeptides were required for this
process in vitro. Several other observations support a
role for Polb and Lig3 in the repair of direct SSBs. First,
Polb inhibitors reduce gap filling in permeabilized mam-
malian cells treated with bleomycin, a radiomimetic
agent that induces primarily direct SSBs, and a con-
certed role for Polb and Lig3 has been reported during
the repair of direct SSBs by human cell extract (Miller
and Chinault, 1982a, 1982b; Winters et al., 1992, 1999).
It is also worth noting that we observe a weak defectFigure 7. Involvement of Polb and Lig3 in SSBR Mediated by Cell
Extract in SSBR in reactions employing low concentrations of
(A) Left, EM9 cells were electroporated in the presence of either EM9 whole-cell extract that is unrelated to the type of
recombinant human PNK, recombinant XRCC1 (“X”), or BSA as a termini present at the SSBs (unpublished data). This
negative control. The cells were then plated, exposed to 0–1 mg/ suggests that in addition to its requirement for end pro-
ml EMS for one hour, and surviving colonies counted after 10 days.
cessing, XRCC1 may also increase the efficiency of gapSurvival was calculated by dividing the number of colonies present
filling and/or ligation by Polb and Lig3 at direct SSBs.on treated plates by the number present on untreated plates. Right,
A similar requirement for XRCC1 has been observedpooled populations of stable HeLa cell transfectants harboring
pcD2E empty vector (“EV”) or pcD2E containing a PNK ORF cloned during the repair of indirect SSBs during base excision
in either sense (“S”) or anti-sense (“AS”) orientation were exposed repair, due primarily to the stabilizing effect of XRCC1
to 0–4 mg/ml EMS for 1 hr and survival calculated as described on the cellular level of Lig3, but perhaps also to a weak
above. Experiments are the mean of five independent experiments,
effect on Polb levels or activity (Cappelli et al., 1997).with similar results observed in each.
Although our data implicate the participation of Polb(B) Top, reactions (10 ml) contained substrate-1 (80 nM) and either
in gap filling at direct SSBs, they do not exclude thelacked cell extract (lane 1) or contained 10 mg (lanes 2, 6, 10, and
14), 5 mg (lanes 3, 7, 11, and 15), 2.5 mg (lanes 4, 8, 12, and 16), or involvement of other DNA polymerases, such as Pold
1.25 mg (lanes 5, 9, 13, and 17) of total protein from EM9-X cell extract and Pole. This is because the linear oligonucleotide sub-
that was immunodepleted with the following: protein G beads (lanes strates employed in our experiments are poor substrates
2–5), protein G/anti-Polb antibody beads (lanes 6–9), protein G/anti-
for the latter enzymes. Indeed, it has been reported thatPolb antibody beads preblocked with Polb (lanes 10–13), or protein
one or both of Pold and Pole can complete the repair ofG beads preblocked with Polb (lanes 14–17). Bottom, reactions (10
direct SSBs mediated by cell extract (Winters et al.,ml) contained substrate-1 (80 nM) and either lacked cell extract (lane
1) or contained 10 mg (lanes 2, 6, 10, and 14), 5 mg (lanes 3, 7, 11, 1999). This ability of different DNA polymerases to con-
and 15), 2.5 mg (lanes 4, 8, 12, and 16), or 1.25 mg (lanes 5, 9, duct gap filling in vitro suggests that some redundancy
13, and 17) of total protein from EM9-X cell extract additionally may exist in the polymerase employed for this process
containing the indicated antibodies. Reaction products were sepa-
in cells. Indeed, such redundancy has been demon-rated by denaturing PAGE and analyzed by phosphorimager.
strated for Polb during gap filling at indirect SSBs during
base excision repair (Frosina et al., 1996; Stucki et al.,
1998; Sobol et al., 2000), and a similar redundancy ataged termini and thereby accelerates the overall repair
direct SSBs could explain the lack of sensitivity ofreaction. These data demonstrate a concerted role for
Polb2/2 cells to ionizing radiation (Miura et al., 2000).XRCC1 and PNK in processing damaged DNA termini
in vitro. Several observations also strongly implicate
XRCC1 and PNK in this role in cells. First, protein ex- The Architecture and Coordination
of Mammalian SSBRtracts from XRCC1 mutant EM9 cells exhibit a reduced
ability to repair SSBs possessing the 59-hydroxyl or An early step in the cellular repair of both direct and
indirect SSBs appears to be rapid binding by poly (ADP-39-phosphate termini that are substrates for PNK in vitro,
but a largely normal ability to repair breaks possessing ribose) polymerase-1 (PARP-1), a molecular “nick sen-
sor” that is activated at SSBs and synthesizes negativelyundamaged termini. Moreover, the role normally fulfilled
by XRCC1 at 59-hydroxyl/39-phosphate damaged ter- charged polymers of ADP-ribose (de Murcia and de Mur-
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access to the SSB termini on the outside bend (steps
2 and 3). This notion is prompted by elegant structural
studies that suggest that XRCC1 and Polb do indeed
encompass SSBs in this way (Sawaya et al., 1997; Marin-
tchev et al., 1999; Rice, 1999).
The model presented above is in accordance with one
recently proposed for base excision repair, in which
protein–DNA complexes assembled for one step of the
pathway are subsequently “recognized” by a protein
that mediates the next step (Rice, 1999; Mol et al., 2000a,
2000b; Wilson and Kunkel, 2000). One advantage of or-
ganizing SSBR in this way, in which the product of one
enzymatic step is “handed” to the enzyme responsible
for the next step, might be to prevent the DNA intermedi-
ates of the repair process from erroneous access by
exonucleases or recombination proteins. A second ad-
vantage may be an increased activity of the individual
polypeptides that comprise the repair process, as sug-
gested by the stimulatory effect of XRCC1 on PNK. This
could reflect an effect on DNA structure caused by one
protein that subsequently increases the activity of an-
other protein. For example, perhaps XRCC1 helps main-
tain the bent conformation of DNA during steps 2–4 and
thereby increases access of the SSB termini to the other
repair proteins. Alternatively, increased activity of indi-
vidual components of the repair process may result from
an effect of specific protein–protein interactions on ei-
ther the catalytic mechanism of an enzyme (e.g., by
affecting protein folding) or its affinity for DNA substrate
(thereby increasing substrate binding). With respect to
the latter, the affinity of PNK for the SSB in step 2 may
be increased by the ability of this protein to “dock” with
XRCC1 and Lig3. Similarly, the affinity of Polb for the
SSB in step 3 may be increased by an ability to “dock”
with XRCC1 and PNK.
In summary, our data suggest a model in which an
XRCC1 protein scaffold orchestrates the architecturalFigure 8. A Model for Mammalian SSBR
choreography of mammalian DNA single-strand breakTop, a direct SSB comprised of a 1 bp gap with 39-phosphate and
repair. In particular, we demonstrate that XRCC1 stimu-59-hydroxyl damaged termini.
lates the activity of polynucleotide kinase at the onset[1] PARP binds to the inside bend of an SSB and is activated,
synthesising large negatively charged ADP-ribose polymers. Acti- of SSBR and thereby accelerates the overall repair re-
vated PARP sequesters XRCC1–Lig3 complex, which then replaces action.
PARP at the inside bend of the SSB. [2] PNK is sequestered for
end processing by simultaneous interaction with the SSB and with
Experimental ProceduresXRCC1–Lig3 complex, both subunits of which bind and stimulate
PNK. [3] Polb is sequestered for gap filling by simultaneous interac-
2-Hybrid Analysistion with the SSB, XRCC1, and PNK. [4] XRCC1-Lig3 completes
2-hybrid pAS1CYH2 or pACT2 constructs encoding human XRCC1repair. Notice the bent configuration of DNA at the site of the SSB.
or Lig3a have been described previously (Caldecott et al., 1996) orStructural studies support the notion that PARP and XRCC1 bind
were generated during this study (pAS-3). pACT1 constructs encod-the inside of this bend and Polb binds the outside, on which the
ing Polb (pACT-b) or PNK (pACT-P) were obtained from a humanSSB is located (de Murcia and Menissier de Murcia, 1994; Sawaya
cDNA library present in pACT by the XRCC1 interaction screenet al., 1997; Marintchev et al., 1999; Rice, 1999).
described below. pAS-P was generated by subcloning the PNK
ORF from pACT-P into pAS1CYH2. To clone human cDNA encoding
proteins that interact with XRCC1, Y190 cells harboring pAS-X were
cia Menissier, 1994; Trucco et al., 1998). The role of transformed with a pACT human cDNA library and plated onto 25
PARP-1 is unclear, but may include sequestering other mM 3-AT plates lacking hisitidine. DNA recovered from individual
His1/b-gal1 clones was transformed into XL2Blue electrocompetentrepair proteins to sites of SSBs (Figure 8, step 1). This
cells (Stratagene) and the recovered pACT plasmids sequencedis supported by the observed ability of activated PARP-1
(LARK Technologies) using 59 and/or 39 primers specific for pACT1.to interact with XRCC1 (Caldecott et al., 1996; Masson
et al., 1998; Dantzer et al., 1999), which we propose then
Yeast, Human, and CHO Protein Extractsserves as a molecular scaffold to coalesce PNK, Polb,
Pelleted yeast Y190 cells (1 3 109) were resuspended in 1 ml of 100and Lig3 at the SSB (Figure 8, steps 2 and 3). We also
mM KCl, 10% glycerol, 50 mM sodium phosphate (pH 8), 1mM DTT,
propose that XRCC1 binds the inside bend of DNA at and 1mM PMSF and lysed by vortexing with glass beads. Clarified
an SSB and thereby can serve as a “docking” platform extracts (2 mg/ml total protein) were stored at 2808C. Whole-cell
extracts were prepared from confluent monolayers of HeLa orfor PNK and Polb while still allowing these enzymes
Cell
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AsPC-1 human cells (0.5–1.0 3 108cells; 0.5 ml packed cell volume), and funds from the Canadian Cancer Society, and M. W. is funded
by the Medical Research Council of Canada.or EM9-V or EM9-X CHO cells (3 3 107cells), by sonication in 1.75
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